Valuation: Becton, Dickinson and Company

Market Cap 51.11B 43.76B 40.83B 37.46B 70.39B 4,890B 71.78B 484B 189B 2,451B 192B 188B 8,113B P/E 2026 *
36.2x
P/E 2027 * 20.2x
Enterprise Value 66.99B 57.36B 53.52B 49.11B 92.27B 6,410B 94.09B 635B 247B 3,212B 252B 246B 10,635B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.3x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.13%
1 day-0.65%
1 week+1.88%
Current month+14.13%
1 month+19.15%
3 months+28.28%
6 months+4.10%
Current year-2.29%
1 week 156.05
Extreme 156.05
162.4
1 month 133.55
Extreme 133.55
162.4
Current year 121.45
Extreme 121.45
179.95
1 year 121.45
Extreme 121.45
179.95
3 years 121.45
Extreme 121.45
261
5 years 121.45
Extreme 121.45
264.8
10 years 121.45
Extreme 121.45
264.8
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+1.88% - - 51.11B
-0.25%+2.58%-13.82%+10.06% 198B
-1.94%+1.90%-0.99%+13.22% 118B
-0.76%+1.51%+3.62%+74.44% 60.05B
-1.37%-6.57%+28.86%+58.31% 53.18B
+0.01%+3.10%-5.81%-31.45% 51.11B
+0.38%-1.38%+10.47%-14.93% 34.05B
-3.92%-8.43% - - 28.58B
+0.28%+2.20%+43.59%-8.77% 24.9B
-0.49%-0.14%-5.53%+5.30% 22.98B
Average -0.87%-0.37%+7.55%+13.27% 65.61B
Weighted average by Cap. -0.83%+0.83%-0.14%+15.85%

Financials

2026 *2027 *
Net sales 19.29B 16.52B 15.41B 14.14B 26.57B 1,846B 27.09B 183B 71.27B 925B 72.43B 70.86B 3,063B 19.73B 16.9B 15.76B 14.46B 27.18B 1,888B 27.71B 187B 72.9B 946B 74.09B 72.48B 3,133B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2.02B 13.61B 5.31B 68.89B 5.39B 5.28B 228B 2.34B 2B 1.87B 1.71B 3.22B 224B 3.29B 22.17B 8.64B 112B 8.78B 8.59B 371B
Net Debt 15.88B 13.6B 12.69B 11.64B 21.88B 1,520B 22.31B 151B 58.68B 762B 59.64B 58.35B 2,522B 13.95B 11.95B 11.15B 10.23B 19.22B 1,335B 19.6B 132B 51.54B 669B 52.39B 51.25B 2,215B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
19/08/26 162.40 +1.37%
19/08/26 €160.20 +2.10%
18/08/26 €156.90 -0.82%
17/08/26 €158.20 +0.25%
14/08/26 €157.80 -1.00%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
187.62USD
Average target price
194.42USD
Spread / Average Target
+3.62%

Quarterly revenue - Rate of surprise